Merck Reports Keytruda Improved Progression-Free Survival in Endometrial Cancer Trial
Merck said Keytruda demonstrated a significant improvement in progression-free survival in an endometrial cancer trial.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.